SCHEMBL25460808

SCHEMBL25460808

CNC(=O)C(C)(C)c1cc(F)cc(C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HCAR1 Q9BXC0 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.37
▸ PPARA Q07869 3/20 0.36
▸ HCAR2 Q8TDS4 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CES2 O00748 1/20 0.34
▸ CES1 P23141 1/20 0.34
▸ SYK P43405 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TPMT P51580 1/20 0.33
▸ TACR1 P25103 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ NCOR2 Q9Y618 1/20 0.33
▸ EPHX2 P34913 1/20 0.33
▸ NR1H4 Q96RI1 1/20 0.33
▸ FABP4 P15090 1/20 0.33
▸ MRGPRX4 Q96LA9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25460811 0.86 SLC6A3 (0.40) SLC6A3CES2CES1MEN1KMT2A
SCHEMBL25460797 0.86 PARP1 (0.39) SLC6A3L3MBTL1CES2CES1HDAC3
SCHEMBL25460807 0.81 CNR2 (0.35) SLC6A3MEN1KMT2ATACR1HDAC3
SCHEMBL25460884 0.80 MAPT (0.49) CES2TACR1HDAC3
SCHEMBL25460880 0.80 CA12 (0.40) HCAR1SLC6A3MEN1KMT2ATACR1
SCHEMBL17896562 0.79 HCAR1 (0.53) HCAR1SLC6A3HCAR2CES2CES1
SCHEMBL25460876 0.79 HDAC3 (0.34) SLC6A3TACR1HDAC3NCOR2
SCHEMBL25464125 0.79 GRM5 (0.39) HCAR1TACR1EPHX2
SCHEMBL24526539 0.78 HCAR1 (0.52) HCAR1SLC6A3PPARAHCAR2L3MBTL1
SCHEMBL25460883 0.76 AKR1C3 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR HCAR1 589/4885SLC6A3 741/4885PPARA 671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback